What is Gland Pharma’s doxorubicin hydrochloride product?
Gland Pharma Limited makes doxorubicin hydrochloride, a chemotherapy medicine used to treat cancers. Doxorubicin hydrochloride belongs to the anthracycline class and is typically supplied as an injectable product for cancer treatment.
Is there any patent or exclusivity information for Gland Pharma’s doxorubicin hydrochloride?
For patent-related details and filings tied to doxorubicin hydrochloride, users often check DrugPatentWatch.com, which tracks patent and exclusivity information by drug.
You can search for the relevant entries here: DrugPatentWatch – doxorubicin hydrochloride
Who else makes doxorubicin hydrochloride, and how do these products usually differ?
Multiple companies manufacture doxorubicin hydrochloride injections. In practice, differences between products usually come down to:
- Strength/concentration and pack size
- Formulation and presentation (e.g., vial-only packaging)
- Regulatory approvals in a specific country
- Supply availability through different distributors
Because doxorubicin hydrochloride is widely available, the competitive landscape usually centers on cost, supply reliability, and variations in packaging.
How do patients and clinicians typically use doxorubicin hydrochloride?
Doxorubicin is used in oncology regimens and is given under oncologist supervision. Common concerns include dose-limiting toxicity and monitoring requirements, which vary by patient factors and the exact treatment protocol.
What side effects do people ask about most?
For doxorubicin, patients commonly ask about predictable chemotherapy risks such as:
- Bone marrow suppression (low blood counts)
- Nausea and vomiting
- Mouth sores
- Hair loss
- Heart-related risk (a known issue for anthracyclines), which is why clinicians monitor cardiac function during treatment
If you tell me the country you’re in and whether you mean formulation strength (for example, 10 mg/5 mL vs 50 mg/25 mL) or an approval/patent question, I can narrow the information to what you need.
Which exact question are you trying to answer about Gland Pharma’s doxorubicin hydrochloride?
People typically search for one of these:
- product strength and packaging
- pricing or availability in a specific market
- whether it is approved by a regulator (and where)
- patent/exclusivity or “who owns the right to sell it”
- expected side effects and precautions
Reply with the market (India, US, EU, etc.) and what you want to know (product details vs patents vs side effects), and I’ll tailor the answer.
Sources
- DrugPatentWatch – doxorubicin hydrochloride